BUGS Bioscience specialises in pathogen genomics and is a leading supplier of high quality molecular surveillance solutions and services.Our proprietary technology platform integrates high throughput molecular approaches with advanced algorithms and software in order to reveal new insights into the genomic composition of bacteria and viruses in complex clinical samples.From our London based service laboratory we currently provide pharmaceutical companies and NGOs involved in vaccine development and roll-out with advanced molecular surveillance services in order to deliver improved understanding of vaccine impact on pathogen carriage and associated disease.Uniquely BUGS Bioscience maintains close links with leading academic groups in the field, both through their contribution to our technology but also through our commitment to a business model in which profits from our commercial operations are reinvested in improving the global molecular surveillance of infectious diseases.